Oncology Treatment Pathway Optimizer
Generate evidence-based oncology treatment pathways with staging and prognostic integration
What You Can Do
You can synthesize complex patient data—histopathology, molecular profiling, imaging findings, and comorbidities—into structured treatment recommendations aligned with NCCN, ESMO, and ASCO guidelines. The skill accelerates the pathway from diagnosis to actionable decisions by organizing multifactorial information, stratifying risk, flagging guideline-discordant scenarios, and integrating emerging evidence like clinical trial eligibility and novel biomarkers into conventional staging systems.
Features
Correlate TNM staging, molecular markers, and genomic profiling with guideline-recommended pathways
Calculate risk scores and prognosis based on tumor characteristics, performance status, and comorbidities
Structure recommendations requiring input from surgery, radiation, medical oncology, and supportive care
Cross-reference NCCN, ESMO, and ASCO recommendations with current published evidence
Identify trial eligibility criteria and match patient characteristics to active studies
Evaluate outcomes and trade-offs across surgery, chemotherapy, radiation, immunotherapy, and targeted therapy options
Generate rationale for pathway deviations when institutional protocols or patient factors diverge from standard recommendations
Assess how performance status, organ function, and concurrent conditions modify standard treatment algorithms
Example Output
Example 1: Stage III Non-Small Cell Lung Cancer
Patient Summary: 62-year-old, ECOG 1, stage IIIA adenocarcinoma, PD-L1 50%, EGFR wild-type
Recommended Pathway:
- Concurrent chemoradiotherapy (cisplatin/pemetrexed + 60 Gy) followed by consolidation durvalumab
- Rationale: PACIFIC trial supports immunotherapy post-chemoradiation; PD-L1 50% favorable for consolidation
- Comorbidity Note: ECOG 1 tolerable; baseline pulmonary function required given thoracic radiation
- Trial Eligibility: Consider enrollment in ongoing PD-L1 biomarker-driven trials
Example 2: Metastatic Colorectal Cancer with MSI-H
Patient Summary: 54-year-old, ECOG 0, metastatic CRC, microsatellite instability-high, BRAF wild-type
Recommended Pathway:
- First-line: pembrolizumab monotherapy (preferred per KEYNOTE-177) OR nivolumab + ipilimumab
- Rationale: MSI-H status predicts durable response to checkpoint inhibition; avoid cytotoxic chemotherapy as first-line
- Prognostic Note: MSI-H status favorable; consider minimal residual disease monitoring
- Alternative if comorbidities preclude immunotherapy: FOLFOXIRI + bevacizumab
Example 3: Early-Stage Breast Cancer (HER2+)
Pathway Decision Tree:
- Hormone Receptor Status: ER/PR negative → omit endocrine therapy
- HER2 Amplification: Use trastuzumab-based regimen (12 months)
- Lymph Node Involvement: 1-3 nodes → consider de-escalation (HER2-directed monotherapy without chemotherapy if low recurrence risk)
- Germline Testing: BRCA1/2 mutation carrier → discuss taxane sensitivity and surveillance implications
What's Included
- SKILL.md: Complete instruction set for pathway analysis and recommendation generation
- Staging Reference Template: TNM staging correlations and prognostic factor integration framework
- Guideline Decision Algorithm: NCCN/ESMO/ASCO pathway flowcharts for major cancer types (lung, colorectal, breast, prostate, lymphoma, pancreatic)
- Risk Stratification Checklist: Prognostic variables, biomarker interpretation, and comorbidity weighting schema
- Clinical Trial Matching Framework: Inclusion/exclusion criteria cross-reference and trial eligibility assessment workflow
- Treatment Modality Comparison Matrix: Outcomes, toxicity profiles, and decision rationale template across surgery, chemotherapy, radiation, immunotherapy, and targeted therapy
Who It's For
- Oncologists — designing evidence-based treatment plans and preparing tumor board presentations
- Medical Oncology Fellows — learning systematic pathway selection and guideline integration
- Tumor Board Coordinators — structuring multidisciplinary case presentations with clear decision rationale
- Radiation Oncologists — integrating radiation recommendations into multimodal treatment pathways
- Surgical Oncologists — evaluating surgical candidacy within multimodal treatment strategies
Best For
- Initial treatment recommendation development post-staging
- Molecular and genomic result integration into pathway selection
- Tumor board case preparation with risk stratification
- Clinical trial eligibility screening and matching
- Guideline-concordant vs. discordant pathway documentation and justification
- Comorbidity-adjusted treatment algorithm modification
- Second opinion case analysis and evidence synthesis
You might also like
You can create comprehensive, evidence-based perioperative pain management protocols tailored to individual patient characteristics and surgical requirements. The skill assesses patient risk factors, recommends optimized multimodal analgesia regimens with specific drug selections and dosing rationales, incorporates regional techniques when appropriate, and identifies contingency plans for inadequate pain control or contraindications. This enables you to move beyond generic guidelines toward truly personalized pain management strategies that reduce opioid exposure while maintaining analgesia.
by gptomics
You can systematically analyze complex oral surgical cases by generating comprehensive pre-operative plans that consider osseous anatomy, neurovascular structures, and patient-specific risk factors. Claude structures multifactorial surgical analysis into actionable operative protocols, risk stratification reports, and detailed procedural workflows that reduce surgical time and improve clinical outcomes while providing medical-legal documentation.
by gptomics
Conduct comprehensive sports injury assessments using standardized orthopedic tests, mechanism-of-injury analysis, and functional capacity evaluation. You'll document findings in insurance-compliant formats, identify red flags requiring referral, establish objective baseline measurements for progress tracking, and generate evidence-based return-to-play recommendations with clear functional milestones.
by gptomics
This skill guides you through structured psychiatric case formulation using a biopsychosocial framework. You input patient presentation, assessment data, and clinical history, then receive a comprehensive formulation that integrates symptom synthesis, differential diagnosis reasoning, predisposing/precipitating/perpetuating factors, protective factors, and evidence-based treatment recommendations. The output is suitable for clinical documentation, insurance authorizations, case conferences, and supervision.
by gptomics
You can rapidly synthesize complex patient data—comorbidities, functional status, labs, medications—into a comprehensive risk profile and actionable optimization plan. This skill guides you through ASA classification, procedure-specific risk stratification, and patient-centered consent documentation to ensure thorough clinical reasoning and defensible preoperative assessment.
by gptomics
You'll develop comprehensive, hierarchical differential diagnoses that integrate clinical reasoning principles with patient safety. This framework helps you identify 'can't-miss' diagnoses, challenge diagnostic assumptions, and sequence diagnostic workup logically—whether managing complex presentations, atypical symptoms, or high-stakes clinical decisions in primary care, urgent care, or specialty settings.
by gptomics
You can convert clinical observation notes, standardized assessment results (FIM, COPM, AMPAC, etc.), and patient history into professionally formatted occupational therapy functional assessment reports. The skill synthesizes raw data into cohesive narratives that document baseline function, identify specific functional limitations, justify interventions to insurance companies, and establish measurable treatment goals—reducing hours of manual documentation while ensuring compliance with insurance requirements and clinical standards.
by gptomics
This skill transforms fragmented OT assessment findings—ROM measurements, strength tests, ADL observations—into cohesive clinical narratives that connect impairment to functional limitation to participation restriction. You'll generate SMART goals that satisfy both clinical rigor and insurance reimbursement standards, and build intervention plans with explicit evidence-based rationale that accelerates authorization and justifies medical necessity to payers.
by gptomics